← All trials
NCT06368856
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 29, 2024
- Primary completion
- Nov 30, 2024
- Completion date
- Mar 31, 2025
- First posted
- Apr 16, 2024
- Last posted
- Apr 16, 2024
- Enrollment
- 40
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LyonLead sponsor
- University of LyonOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.